One68 Global Capital, LLC Petros Pharmaceuticals, Inc. Transaction History

One68 Global Capital, LLC

  • $0
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.41 - $5.29 $10,202 - $131,631
-24,883 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.24 - $4.68 $80,620 - $116,452
24,883 New
24,883 $109,000

About Petros Pharmaceuticals, Inc.

PTPI Quotes by TradingView
  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $6.42M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track One68 Global Capital, LLC Portfolio

Follow One68 Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One68 Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One68 Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email